Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

CORDIS reúne toda la información sobre los proyectos financiados por Horizonte 2020 , y ahora también resúmenes de los informes relacionados. Se puede descargar toda la documentación de estos proyectos en el Portal de datos abiertos de la UE .

My refinements

Download results of this page

Restringir por:

Tipo de contenido

Proyecto (25)

Advanced search

Búsqueda de proyectos y resultados

Results 1 - 10 of 25
12 3 > 
BACTerial detection and CONtrol of urinary tract infection
ID: 663090
Fecha de inicio: 2015-03-01, Fecha de finalización: 2015-04-30
Problem Approx. 50% of all patients with severe blood stream infections die from the infections, while the remaining 50% incur excessive socio-economic expenses from prolonged hospital stays. In fact, the fourth largest cause of death in the western world is hospital and care...
Programme: H2020-EU.3.1.3.
Record Number: 196228
Last updated on: 2015-03-25
ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020
ID: 643417
Fecha de inicio: 2015-01-01, Fecha de finalización: 2019-12-31
Over 12 million people in Europe suffer from neurodegenerative diseases (ND), yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery...
Programme: H2020-EU.3.1.3.
Record Number: 194063
Last updated on: 2017-08-22
REgeneration of inner ear hair cells with GAmma-secretase INhibitors to regain hearing in patients with sensorineural hearing loss
ID: 634893
Fecha de inicio: 2015-05-01, Fecha de finalización: 2018-10-31
Hearing loss is a chronic non-communicable disease disabling over 328 million adults, and 32 million children worldwide. Sensorineural hearing loss due to loss of auditory hair cells was long thought to be irreversible. However, recent animal studies have demonstrated that...
Programme: H2020-EU.3.1.3.
Record Number: 193313
Last updated on: 2017-07-10
INtestinal Tissue ENgineering Solution
ID: 668294
Fecha de inicio: 2016-01-01, Fecha de finalización: 2020-12-31
Short Bowel Syndrome (SBS) is a condition that occurs when part or the entire small intestine is missing or has been removed during surgery. This condition renders the bowel incapable of fulfilling its nutritional function (intestinal failure). There is no cure for SBS...
Programme: H2020-EU.3.1.3.
Record Number: 199751
Last updated on: 2017-02-22
AntibioDx: A groundbreaking in vitro diagnostic device with a billion-dollar sales potential
ID: 697471
Fecha de inicio: 2015-09-01, Fecha de finalización: 2016-02-29
When diagnosing bloodstream infection (BSI), 19th century blood culture is essentially still the gold standard method - despite the highly critical 1-2 days delay from sample to result. Many cases of BSI remain undertreated in the early and highly critical stage of the...
Programme: H2020-EU.3.1.3.
Record Number: 198902
Last updated on: 2015-09-02
Efficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trial
ID: 754640
Fecha de inicio: 2018-01-01, Fecha de finalización: 2022-12-31
TENSION (efficacy and safety of ThrombEctomy iN Stroke with extended leSION and extended time window: a randomized, controlled trial) strives at providing innovative treatment to patients with severe stroke to reduce the individual and societal burden of death and dependency...
Programme: H2020-EU.3.1.3.
Record Number: 212667
Last updated on: 2018-01-18
PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation
ID: 754517
Fecha de inicio: 2017-12-01, Fecha de finalización: 2022-11-30
Intracerebral hemorrhage (ICH) is a severe stroke subtype causing higher mortality and more disability than other strokes. 20% of ICH survivors have atrial fibrillation (AF), a major cause of ischemic stroke (IS). While IS in AF patients is generally prevented by oral...
Programme: H2020-EU.3.1.3.
Record Number: 212666
Last updated on: 2018-01-18
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
ID: 733008
Fecha de inicio: 2017-01-01, Fecha de finalización: 2022-12-31
IMMUNOSABR is geared towards opening up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy. High precision stereotactic ablative radiotherapy (SABR) is combined with immunotherapy to form a...
Programme: H2020-EU.3.1.3.
Record Number: 207443
Last updated on: 2017-07-17
Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection
ID: 731626
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-12-31
The main goal of HIVACAR proposal is to change the current paradigm of HIV treatment by obtaining a functional cure for HIV (i.e., control of viral load to levels below the threshold of 50 copies/ml and maintenance of high CD4+ T-cell count after discontinuation of...
Programme: H2020-EU.3.1.3.
Record Number: 207437
Last updated on: 2016-12-15
Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study
ID: 731532
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-06-30
Chronic angina pectoris is a debilitating chronic disease, a subgroup of these patients suffers from refractory angina which unfortunately can’t be controlled by medical therapy (angioplasty or surgery). Refractory angina is a substantial burden on the individual and...
Programme: H2020-EU.3.1.3.
Record Number: 207197
Last updated on: 2017-05-23
12 3 > 
List retrieved on: 2018-08-20
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba